Our research demonstrates that CD58 promotes glioma cell proliferation, invasion, and migration, consistent with previous findings showing elevated CD58 levels correlate with poor prognosis in various tumors (17–19, 22). This evidence concerns the gene CD58 and central nervous system cancer.